Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

This study is testing the safety, effectiveness, and drug behaviour of LP-003, a new injectable drug for people with allergic asthma that is not adequately controlled despite using medium-to-high dose inhaled corticosteroids. Allergic asthma is triggered by allergens like dust mites, pollen, or pet dander. **You may be eligible if...** - You are 18–75 years old - You have been diagnosed with allergic asthma for at least 1 year, with at least one flare-up in the past year - You have a positive allergy test (skin prick or blood test) for a relevant allergen - Your asthma is still not well-controlled despite being on medium-to-high dose inhaled steroids for at least 8 weeks - You have an ACT (Asthma Control Test) score of 19 or below **You may NOT be eligible if...** - You have non-allergic asthma or no confirmed allergen trigger - Your asthma is well-controlled on your current medications - You do not meet the minimum dose of inhaled steroids required for the study Talk to your doctor to see if this trial is right for you.